RecruitingNCT06625216

Severe Asthma Network Italy

Observatory of Patients With Severe Asthma and Potential Eligible Patients for Treatment With Biological Drugs

Sponsor

Società Italiana di Allergologia, Asma e Immunologia Clinica

Enrollment

5,000 participants

Start Date

Feb 17, 2017

Study Type

OBSERVATIONAL

Conditions

Severe Asthma

Summary

The goal of this registry is collecting data of severe asthma patients, recruited by specialized centers, in a real life setting, homogeneously placed on a database management system to follow them over the time. The information recorded will provide: 1. The collection of homogeneous clinical, functional and biologic data of patients with severe asthma in a real life setting. 2. The evaluation of adherence to treatment in real life. 3. The clinical eligibility of patients treated with biologics. 4. The evaluation of patients' clinical response to each treatment. 5. The monitoring of tolerability and safety. 6. The long-term follow up of patients with severe asthma.

Eligibility

Min Age: 13 Years

Plain Language Summary

Simplified for easier understanding

This Italian registry study is collecting real-world data on people with severe asthma to better understand how the condition is managed in everyday clinical practice. There are no experimental treatments — it is an observational study that tracks outcomes over time. **You may be eligible if...** - You are 12 years or older - You have been diagnosed with severe asthma according to international guidelines - Your asthma requires high-dose inhaled steroids plus another controller medication, or oral steroids for more than 6 months per year - You still experience poor control, frequent attacks, or reduced lung function despite treatment - You have signed informed consent **You may NOT be eligible if...** - You do not have a confirmed diagnosis of severe asthma Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.